Bristol’s Growth Plan Faces First Test In 2022

New Drugs Hit $1bn Mark In 2021, But First Revlimid Generics Launch This Year

 
• By Mandy Jackson
  
Set of Three Increasing Size Red and White Cartoon Spaceships on Dark Background
BMS will launch three new products, pending approvals, in the US in 2022 • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Earnings

More from Business